Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,470 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Recruiting

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT07665515

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital Cambridge, United Kingdom
  • The University of Edinburgh - Western General Hospital - Edinburgh Cancer Research Centre Edinburgh, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • St. James's University Hospital Leeds, United Kingdom
View Trial Details
Recruiting

A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer

NCT07042802

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Obstetrics and Gynecology Hospital Capital Medical University Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Recruiting

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

NCT07546500

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Site 0107 Phoenix, Arizona, United States
  • Site 0110 Antioch, California, United States
  • Site 0115 San Francisco, California, United States
  • Site 0101 Torrance, California, United States
View all 59 locations
View Trial Details
Recruiting

A Study of PHST001 in Advanced Solid Tumors

NCT06840886

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +27 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One Denver, Colorado, United States
View all 20 locations
View Trial Details
Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START-New York Long Island Lake Success, New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details

Related conditions